Hospital Readmission in Patients With Diabetic Foot Ulcers: Prevalence, Causes, and Outcomes.

diabetes diabetic foot ulcers healing hospital admission limb salvage

Journal

The international journal of lower extremity wounds
ISSN: 1552-6941
Titre abrégé: Int J Low Extrem Wounds
Pays: United States
ID NLM: 101128359

Informations de publication

Date de publication:
17 Oct 2023
Historique:
medline: 18 10 2023
pubmed: 18 10 2023
entrez: 18 10 2023
Statut: aheadofprint

Résumé

The aim of the current study was to evaluate the rate of readmission in patients affected by diabetes and foot ulcers (DFUs), and causes and outcomes of patients requiring a new hospitalization. The current study is a retrospective observational study including patients who have required hospitalization since January 2019 to September 2022 due to a DFU. Once patients were discharged, they were regularly followed as outpatients. Within 6 months of follow-up, the rate of hospital readmission for a diabetic foot problem was recorded. According to the readmission or not, patients were divided into 2 groups, readmitted and not readmitted patients, respectively. Hence, all patients were followed for 6 months more and outcomes of the 2 groups were analyzed and compared. Overall, 310 patients were included. The mean age was 68  ±  12 years, the majority of patients reported type 2 diabetes (>90%), and the mean diabetes duration was approximately 20 years. Sixty-eight (21.9%) patients were readmitted. The main reason for hospital readmission was the presence of critical limb ischemia (CLI) in the contralateral limb (6.1%), the recurrence of CLI in the previous treated limb (4.5%), and the onset of new infected DFU in the contralateral foot (4.5%). Readmitted patients reported lower rate of healing (51.5% vs 89.2%,

Identifiants

pubmed: 37849322
doi: 10.1177/15347346231207747
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

15347346231207747

Déclaration de conflit d'intérêts

Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Auteurs

Marco Meloni (M)

Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
University Hospital Fondazione Policlinico Tor Vergata, Rome, Italy.

Aikaterini Andreadi (A)

Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
University Hospital Fondazione Policlinico Tor Vergata, Rome, Italy.

Valeria Ruotolo (V)

Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
University Hospital Fondazione Policlinico Tor Vergata, Rome, Italy.

Maria Romano (M)

Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
University Hospital Fondazione Policlinico Tor Vergata, Rome, Italy.

Ermanno Bellizzi (E)

Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
University Hospital Fondazione Policlinico Tor Vergata, Rome, Italy.

Laura Giurato (L)

Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
University Hospital Fondazione Policlinico Tor Vergata, Rome, Italy.

Alfonso Bellia (A)

Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
University Hospital Fondazione Policlinico Tor Vergata, Rome, Italy.

Luigi Uccioli (L)

Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
University Hospital Fondazione Policlinico Tor Vergata, Rome, Italy.

Davide Lauro (D)

Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
University Hospital Fondazione Policlinico Tor Vergata, Rome, Italy.

Classifications MeSH